Over the past 12 months, 4 insiders at RHYTHM PHARMACEUTICALS, INC. filed 40 open-market SEC Form 4 transactions on RYTM: 0 purchases worth $0 and 40 sales worth $14.7M. Insiders have been net sellers over this period. The most recent filing was on May 15, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 15, 26 | Christopher Paul GermanCorporate Controller & CAO | SELL | 4.6K | $92.21 | $428K |
| Mar 4, 26 | Christopher Paul GermanCorporate Controller & CAO | SELL | 5.6K | $89.56 | $503K |
| Feb 19, 26 | Hunter C SmithChief Financial Officer | SELL | 1.7K | $103.28 | $171K |
| Feb 17, 26 | Hunter C SmithChief Financial Officer | SELL | 1.2K | $103.00 | $119K |
| Feb 12, 26 | Hunter C SmithChief Financial Officer | SELL | 800 | $100.10 | $79K |
| Feb 11, 26 | Hunter C SmithChief Financial Officer | SELL | 2.3K | $100.85 | $223K |
| Feb 10, 26 | Hunter C SmithChief Financial Officer | SELL | 1.9K | $104.76 | $196K |
| Feb 5, 26 | Hunter C SmithChief Financial Officer | SELL | 3.4K | $106.06 | $359K |
| Feb 4, 26 | Hunter C SmithChief Financial Officer | SELL | 1.5K | $107.67 | $157K |
| Dec 11, 25 | Pamela J. CramerChief Human Resources Officer | SELL | 3.4K | $111.00 | $372K |
| Nov 20, 25 | Pamela J. CramerChief Human Resources Officer | SELL | 3.4K | $105.00 | $352K |
| Nov 10, 25 | Pamela J. CramerChief Human Resources Officer | SELL | 3.5K | $100.00 | $352K |
| Nov 7, 25 | Pamela J. CramerChief Human Resources Officer | SELL | 19.4K | $98.82 | $1.9M |
| Oct 30, 25 | Joseph ShulmanChief Technical Officer | SELL | 9.7K | $115.24 | $1.1M |
| Oct 28, 25 | Joseph ShulmanChief Technical Officer | SELL | 2.8K | $115.01 | $324K |
| Oct 16, 25 | Joseph ShulmanChief Technical Officer | SELL | 8.3K | $112.81 | $934K |
| Sep 2, 25 | Joseph ShulmanChief Technical Officer | SELL | 16.8K | $105.30 | $1.8M |
| Aug 21, 25 | Joseph ShulmanChief Technical Officer | SELL | 4.2K | $100.07 | $419K |
| Aug 13, 25 | Hunter C SmithChief Financial Officer | SELL | 3.5K | $96.00 | $334K |
| Aug 12, 25 | Christopher Paul GermanCorporate Controller & CAO | SELL | 1.5K | $95.00 | $143K |
| Aug 12, 25 | Hunter C SmithChief Financial Officer | SELL | 24.6K | $96.33 | $2.4M |
| Aug 11, 25 | Joseph ShulmanChief Technical Officer | SELL | 4.0K | $90.08 | $359K |
| Jul 29, 25 | Pamela J. CramerChief Human Resources Officer | SELL | 1.5K | $85.93 | $131K |
| Jul 9, 25 | Pamela J. CramerChief Human Resources Officer | SELL | 7.8K | $80.00 | $601K |
| Jul 9, 25 | Christopher Paul GermanCorporate Controller & CAO | SELL | 2.0K | $85.00 | $157K |
| Jul 9, 25 | Joseph ShulmanChief Technical Officer | SELL | 4.0K | $80.00 | $319K |
| Jul 9, 25 | Hunter C SmithChief Financial Officer | SELL | 23.4K | $84.50 | $2.0M |
| Jul 2, 25 | Alastair GarfieldChief Scientific Officer | SELL | 1.3K | $64.81 | $85K |
| Jun 10, 25 | Christopher Paul GermanCorporate Controller & CAO | SELL | 2.1K | $67.19 | $139K |
| Jun 6, 25 | Pamela J. CramerChief Human Resources Officer | SELL | 7.0K | $68.05 | $478K |
| Jun 3, 25 | McGirr David W JDirector | SELL | 55.6K | $65.64 | $3.6M |
| Jun 3, 25 | David P MeekerPresident and CEO | SELL | 43.3K | $65.60 | $2.8M |
| May 30, 25 | Hunter C SmithChief Financial Officer | SELL | 19.0K | $61.52 | $1.2M |
| Apr 29, 25 | Pamela J. CramerChief Human Resources Officer | SELL | 7.0K | $65.09 | $458K |
| Apr 29, 25 | Yann MazabraudEVP, Head of International | SELL | 6.7K | $65.08 | $439K |
| Apr 8, 25 | Pamela J. CramerChief Human Resources Officer | SELL | 7.0K | $62.00 | $436K |
| Apr 8, 25 | Yann MazabraudEVP, Head of International | SELL | 9.3K | $61.54 | $573K |
| Mar 21, 25 | Christopher Paul GermanCorporate Controller & CAO | SELL | 344 | $54.23 | $19K |
| Mar 14, 25 | Yann MazabraudEVP, Head of International | SELL | 55.8K | $51.72 | $2.9M |
| Feb 19, 25 | Pamela J. CramerChief Human Resources Officer | SELL | 982 | $57.22 | $56K |
| Feb 19, 25 | Christopher Paul GermanCorporate Controller & CAO | SELL | 635 | $57.22 | $36K |
| Feb 19, 25 | Jennifer Kayden LeeEVP, Head of North America | SELL | 2.0K | $57.22 | $116K |
| Feb 19, 25 | David P MeekerPresident and CEO | SELL | 9.9K | $57.22 | $566K |
| Feb 19, 25 | Joseph ShulmanChief Technical Officer | SELL | 1.2K | $57.22 | $70K |
| Feb 19, 25 | Hunter C SmithChief Financial Officer | SELL | 2.2K | $57.22 | $127K |
| Feb 13, 25 | Jennifer Kayden LeeEVP, Head of North America | SELL | 1.2K | $58.00 | $70K |
| Feb 12, 25 | Jennifer Kayden LeeEVP, Head of North America | SELL | 1.2K | $56.41 | $68K |
| Feb 12, 25 | Joseph ShulmanChief Technical Officer | SELL | 462 | $57.09 | $26K |
| Feb 12, 25 | Hunter C SmithChief Financial Officer | SELL | 739 | $56.39 | $42K |
| Feb 11, 25 | Pamela J. CramerChief Human Resources Officer | SELL | 698 | $57.54 | $40K |
Over the past 12 months, insiders at RHYTHM PHARMACEUTICALS, INC. filed 0 open-market purchases worth $0 and 40 sales worth $14.7M on RYTM, which makes them net sellers over the period. The most recent Form 4 was filed on May 15, 26.
4 different insiders at RHYTHM PHARMACEUTICALS, INC. filed open-market SEC Form 4 transactions on RYTM over the last 12 months.
InsiderTape plots every RYTM insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every RHYTHM PHARMACEUTICALS, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →